Juvenile Paget's disease, familial expansile osteolysis and other genetic osteolytic disorders

Research output: Contribution to journalArticlepeer-review

Abstract / Description of output

Several rare inherited osteolytic disorders have been described that show phenotypic overlap with Paget's disease of bone (PDB). Familial expansile osteolysis, early-onset familial PDB and expansile skeletal hyperphosphatasia are related disorders caused by mutations affecting the TNFRSFIIA gene, which encodes the receptor activator of NF kappa B (RANK). The mutations result in failure of normal processing of RANK and osteoclast activation. Inactivating mutations in the TNFRSFIIB gene, which encodes osteoprotegerin, cause idiopathic hyperphosphatasia which is a severe disorder that shares phenotypic similarities with PDB. The syndrome of hereditary inclusion body myopathy, PDB and frontotemporal dementia is caused by mutations in the gene encoding for valosin-containing protein which is involved in regulating degradation of ubiquitinated proteins. Anecdotal reports indicate that osteoclast inhibitors such as bisphosphonates are effective for suppressing bone turnover and improving symptoms in these disorders, although the long-term effects on clinical outcomes are unclear.

Original languageEnglish
Pages (from-to)101-111
Number of pages11
JournalBest Practice and Research: Clinical Rheumatology
Issue number1
Publication statusPublished - Mar 2008


Dive into the research topics of 'Juvenile Paget's disease, familial expansile osteolysis and other genetic osteolytic disorders'. Together they form a unique fingerprint.

Cite this